ISPC (iSpecimen) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 12, 2026)


ISPC iSpecimen Inc ISPC
49 GF Score
Price $2.50
GF Value $6.66
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is iSpecimen 5-Year Yield-on-Cost %?

iSpecimen ISPC -1.57% 49 5-Year Yield-on-Cost % is 0.00 as of Jul. 12, 2026. GuruFocus rates ISPC with a GF Score™ of 49/100 and a GF Value™ of $6.66 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 65 Medical Diagnostics & Research companies, iSpecimen ranks worse than 1538460% on this metric.

iSpecimen's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for iSpecimen's 5-Year Yield-on-Cost % or its related term are showing as below:



ISPC's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.42
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

iSpecimen  (NAS:ISPC) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


iSpecimen 5-Year Yield-on-Cost % Related Terms


ISPC vs BIAF, FUNI, IVRO: 5-Year Yield-on-Cost % Comparison

For the Diagnostics & Research subindustry, iSpecimen's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iSpecimen 5-Year Yield-on-Cost % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, iSpecimen's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where iSpecimen's 5-Year Yield-on-Cost % falls into.


ISPC
49GF Score
iSpecimen Inc ISPC
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iSpecimen 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of iSpecimen is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
iSpecimen (ISPC) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 12, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on iSpecimen and its competitors. According to the industry distribution chart, iSpecimen ranks #999999 out of 65 companies in the Medical Diagnostics & Research industry.
Is iSpecimen's 5-Year Yield-on-Cost % too high?
iSpecimen's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, iSpecimen ranks #999999 out of 65 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, iSpecimen has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does iSpecimen's 5-Year Yield-on-Cost % compare to BIAF and FUNI?
According to the Medical Diagnostics & Research industry distribution chart, iSpecimen ranks #999999 out of 65 companies for 5-Year Yield-on-Cost %. This places iSpecimen in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Diagnostics & Research company?
The median 5-Year Yield-on-Cost % among Medical Diagnostics & Research companies is 2.42, based on 65 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on iSpecimen and its competitors. For the Medical Diagnostics & Research industry, the median 5-Year Yield-on-Cost % is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iSpecimen's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iSpecimen stock overvalued right now?
Based on GuruFocus' analysis, iSpecimen (ISPC) is currently considered Possible Value Trap. The stock's GF Value™ is $6.66, compared to a current price of $2.50 — trading 62.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. iSpecimen's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For iSpecimen (ISPC), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iSpecimen (ISPC) Overvalued in 2026?

Based on GuruFocus' analysis, iSpecimen stock appears to be undervalued. The current stock price of $2.50 is trading 62.5% below its estimated GF Value™ of $6.66. GuruFocus considers iSpecimen to be Possible Value Trap.

Key valuation signals for ISPC:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $6.66 vs. price of $2.50 (62.5% below fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the ISPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


iSpecimen Business Description

Address 8 Cabot Road, Suite 1800, Woburn, MA, USA, 01801
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
49GF Score

Get the complete analysis for ISPC

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.50
Price
$6.66
GF Value